时间分辨CT侧支循环评估作为预测急性缺血性卒中临床结局的影像生物标志物
该回顾性研究纳入135例接受静脉组织型纤溶酶原激活剂治疗的前循环卒中患者,用机器学习软件定量评估侧支循环评分,并构建校正年龄、基线NIHSS和再通状态的方程预测90天改良Rankin量表结局;侧支评分在再通患者中是良好临床结局的显著预后标志物(p<0.033),在未再通患者中不显著(p<0.497),且为预测性标志物(p<0.044)。
要点
- 侧支评分在再通患者中预测良好临床结局有统计学意义(p<0.033),未再通患者中不显著(p<0.497)。
- 侧支评分是预测性生物标志物(p<0.044),良好侧支者从成功再通中获益更多。
- 侧支循环差者即使再通临床结局仍差,侧支状态在未再通时无足轻重。
核心结论
- 侧支评分是再通患者良好临床结局的显著预后标志物(p<0.033),在未再通患者中不显著(p<0.497),同时为预测性标志物(p<0.044)。
- 良好侧支评分患者从成功再通中获益多于侧支评分差者,侧支状态在未实现再通时无足轻重。
- 数据强调谨慎选择再通治疗患者以避免无效再通,侧支稀少预示再通后临床结局仍差,而侧支丰富者因良好结局几率更高值得考虑再通治疗。
研究设计与样本
- 回顾性研究,纳入135例接受静脉组织型纤溶酶原激活剂治疗的前循环卒中患者。
- 采用新型机器学习软件按血管区域无创、客观、定量评估侧支循环,推导校正年龄、基线NIHSS和再通状态的方程预测90天改良Rankin量表临床结局。
- 主要分析确定新侧支评分的预后价值,次要分析检查侧支评分与其他变量的相互关系。
诊断标准与关键数值
- 侧支评分在再通患者中预测良好临床结局p<0.033,在未再通患者中p<0.497。
- 侧支评分为预测性生物标志物p<0.044。
- 结局预测方程校正年龄、基线NIHSS和再通状态,结局指标为90天改良Rankin量表。
临床应用与阅片要点
- 作者认为侧支丰富者因良好临床结局几率更高值得考虑再通治疗,侧支稀少者再通后结局仍差。
- 作者认为应谨慎选择再通治疗患者以避免无效再通。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Collateral circulation plays a pivotal role in the pathophysiology of acute ischemic stroke and is increasingly recognized as a promising biomarker for predicting the clinical outcome. However, there is no single established grading system. We designed a novel machine-learning software that allows non-invasive, objective, and quantitative assessment of collaterals according to their vascular territories. Our goal is to investigate the prognostic and predictive value of this collateral score for the prediction of acute stroke outcome.
METHODS: This is a retrospective study of 135 patients with anterior circulation stroke treated with IV TPA. An equation using this collateral score (adjusting for age, baseline NIHSS, and recanalization) was derived to predict the clinical outcome (90-day mRS). The primary analyses focused on determining the prognostic value of our newly developed collateral scores. Secondary analyses examined the interrelationships between the collateral score and other variables.
RESULTS: The collateral score emerged as a statistically significant prognostic biomarker for good clinical outcome (p < 0.033) among recanalized patients, but not among non-recanalized patients (p < 0.497). Our results also showed that collateral score was a predictive biomarker (p < 0.044). These results suggest that (1) patients with good collateral score derive more benefit from successful recanalization than patients with poor collateral score and (2) collateral status is inconsequential if recanalization is not achieved.
CONCLUSION: Our data results reinforce the importance of careful patient selection for recanalization therapy to avoid futile recanalization. The paucity of collaterals predicts poor clinical outcome despite recanalization. On the other hand, robust collaterals warrant consideration for recanalization therapy given the better odds of good clinical outcome.
引用
- Tong E, Patrie J, Tong S, et al. Time-resolved CT assessment of collaterals as imaging biomarkers to predict clinical outcomes in acute ischemic stroke. Neuroradiology. 2017. PMID: 28864854. doi:10.1007/s00234-017-1914-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。